Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Treasury Shares (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Treasury Shares for 15 consecutive years, with $315000.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 94.11% to $315000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $315000.0 through Dec 2025, down 94.11% year-over-year, with the annual reading at $315000.0 for FY2025, 94.11% down from the prior year.
  • Treasury Shares hit $315000.0 in Q4 2025 for Ironwood Pharmaceuticals, down from $5.4 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $5.4 million in Q4 2024 to a low of $315000.0 in Q4 2025.
  • Historically, Treasury Shares has averaged $3.8 million across 5 years, with a median of $4.3 million in 2022.
  • Biggest five-year swings in Treasury Shares: rose 24.53% in 2023 and later tumbled 94.11% in 2025.
  • Year by year, Treasury Shares stood at $3.9 million in 2021, then grew by 11.03% to $4.3 million in 2022, then increased by 24.53% to $5.3 million in 2023, then increased by 0.16% to $5.4 million in 2024, then crashed by 94.11% to $315000.0 in 2025.
  • Business Quant data shows Treasury Shares for IRWD at $315000.0 in Q4 2025, $5.4 million in Q4 2024, and $5.3 million in Q4 2023.